Semaglutide reduces heart failure events in patients with preserved ejection fraction
1. Patients in the semaglutide group reported fewer heart failure events than those in the placebo group. 2. No significant ...
Tag: atherosclerosis
Assessment of lipid biomarker distribution in dried blood spots for newborn screening
1. In a retrospective cohort study, the distribution of low density lipoprotein cholesterol (LDL-C) and apolipoprotein B (ApoB) levels obtained ...
C-reactive protein may have superior prognostic value compared to low-density lipoprotein cholesterol for patients on statin therapy
1. High-sensitivity C-reactive protein increased the risk of all-cause mortality by two- to three-fold among all three randomized trials. 2. ...
Exercise improves arterial stiffness in children and adolescents
1. In this systematic review and network meta-analysis, resistance training, high-intensity interval training (HIIT), and aerobic exercise interventions were superior ...
Wellness Check: Exercise
Exercise improves arterial stiffness in children and adolescents 1. In this systematic review and network meta-analysis, resistance training, high-intensity interval ...
History of adverse pregnancy outcomes associated with image-identified coronary artery disease
1. In this population-based cross-sectional study, among 10 528 Swedish women undergoing coronary computed tomography (CT) angiography, there was a ...
Pemafibrate does not lower cardiovascular risk in individuals with hypertriglyceridemia
1. In patients with type 2 diabetes and hypertriglyceridemia, pemafibrate did not alter the incidence of cardiovascular events compared to placebo. ...
![Ivabradine ineffective in stable coronary artery disease [SIGNIFY trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/800px-RCA_atherosclerosis-350x250.jpg)
Olpasiran significantly reduces lipoprotein(a) levels in patients with cardiovascular disease
1. Olpasiran significantly and substantially reduced lipoprotein(a) concentration in patients with atherosclerotic cardiovascular disease compared to placebo. 2. Olpasiran reduced ...
Risk of myopathy and myalgia among statin users may be small and clinically insignificant
1. 27.1% of patient in the statin group reported muscle pain and weakness compared to 26.6% in the control groups. ...
Moderate-intensity statin plus ezetimibe is non-inferior to high-intensity statin monotherapy
1. 3-year composite outcome of stroke and cardiovascular disease was comparable between both groups (9.1% combination vs. 9.9% monotherapy). 2. ...